Global Iron Chelation Drug Market Research Report 2012-2024
SUMMARY
The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
The global Iron Chelation Drug market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
The global Iron Chelation Drug market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
- Deferoxamine
- Deferiprone
- Deferasirox
- Apotex Inc. (Canada)
- Cipla (India)
- Novartis (Switzerland)
- Sun Pharma (India)
- Natco Pharma (India)
- Transfusional Iron Overload
- NTDT Caused Iron Overload
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 MARKET OVERVIEW
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Deferoxamine
1.2.1.2 Deferiprone
1.2.1.3 Deferasirox
1.2.2 by Application
1.2.2.1 Transfusional Iron Overload
1.2.2.2 NTDT Caused Iron Overload
1.2.3 by Regions
2 INDUSTRY CHAIN
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 ENVIRONMENTAL ANALYSIS
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 MARKET SEGMENTATION BY TYPE
4.1 Market Size
4.1.1 Deferoxamine Market, 2013-2018
4.1.2 Deferiprone Market, 2013-2018
4.1.3 Deferasirox Market, 2013-2018
4.2 Market Forecast
4.2.1 Deferoxamine Market Forecast, 2019-2024
4.2.2 Deferiprone Market Forecast, 2019-2024
4.2.3 Deferasirox Market Forecast, 2019-2024
5 MARKET SEGMENTATION BY APPLICATION
5.1 Market Size
5.1.1 Transfusional Iron Overload Market, 2013-2018
5.1.2 NTDT Caused Iron Overload Market, 2013-2018
5.2 Market Forecast
5.2.1 Transfusional Iron Overload Market Forecast, 2019-2024
5.2.2 NTDT Caused Iron Overload Market Forecast, 2019-2024
6 MARKET SEGMENTATION BY REGION
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 MARKET COMPETITIVE
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 MAJOR VENDORS
8.1 Apotex Inc. (Canada)
8.2 Cipla (India)
8.3 Novartis (Switzerland)
8.4 Sun Pharma (India)
8.5 Natco Pharma (India)
9 CONCLUSION
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Deferoxamine
1.2.1.2 Deferiprone
1.2.1.3 Deferasirox
1.2.2 by Application
1.2.2.1 Transfusional Iron Overload
1.2.2.2 NTDT Caused Iron Overload
1.2.3 by Regions
2 INDUSTRY CHAIN
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 ENVIRONMENTAL ANALYSIS
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 MARKET SEGMENTATION BY TYPE
4.1 Market Size
4.1.1 Deferoxamine Market, 2013-2018
4.1.2 Deferiprone Market, 2013-2018
4.1.3 Deferasirox Market, 2013-2018
4.2 Market Forecast
4.2.1 Deferoxamine Market Forecast, 2019-2024
4.2.2 Deferiprone Market Forecast, 2019-2024
4.2.3 Deferasirox Market Forecast, 2019-2024
5 MARKET SEGMENTATION BY APPLICATION
5.1 Market Size
5.1.1 Transfusional Iron Overload Market, 2013-2018
5.1.2 NTDT Caused Iron Overload Market, 2013-2018
5.2 Market Forecast
5.2.1 Transfusional Iron Overload Market Forecast, 2019-2024
5.2.2 NTDT Caused Iron Overload Market Forecast, 2019-2024
6 MARKET SEGMENTATION BY REGION
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 MARKET COMPETITIVE
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 MAJOR VENDORS
8.1 Apotex Inc. (Canada)
8.2 Cipla (India)
8.3 Novartis (Switzerland)
8.4 Sun Pharma (India)
8.5 Natco Pharma (India)
9 CONCLUSION
LIST OF TABLES
Table Product Specifications of Iron Chelation Drug
Table Products Segment of Iron Chelation Drug
Table Deferoxamine Overview
Table Deferiprone Overview
Table Deferasirox Overview
Table Global Iron Chelation Drug Market by Type, 2011-2022 (USD Million)
Table Application Segment of Iron Chelation Drug
Table Transfusional Iron Overload Overview
Table NTDT Caused Iron Overload Overview
Table Global Iron Chelation Drug Market by Application, 2011-2022 (USD Million)
Table Global Iron Chelation Drug Market by Region, 2011-2022 (USD Million)
Table Cost of Iron Chelation Drug
Table Market Dynamics
Table Policy of Iron Chelation Drug
Table GDP of Major Countries
Table Deferoxamine CAGR by Revenue and Volume, 2012-2018
Table Deferiprone CAGR by Revenue and Volume, 2012-2018
Table Deferasirox CAGR by Revenue and Volume, 2012-2018
Table Deferoxamine CAGR by Revenue and Volume, 2012-2024
Table Deferiprone CAGR by Revenue and Volume, 2012-2024
Table Deferasirox CAGR by Revenue and Volume, 2012-2024
Table Transfusional Iron Overload CAGR by Revenue and Volume, 2012-2018
Table NTDT Caused Iron Overload CAGR by Revenue and Volume, 2012-2018
Table Global Iron Chelation Drug Market by Vendors, 2012-2018 (USD Million)
Table Global Iron Chelation Drug Market by Vendors, 2012-2018 (in Volume)
Table Global Iron Chelation Drug Market Share by Vendors, 2012-2018 (USD Million)
Table Global Iron Chelation Drug Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Apotex Inc. (Canada) Profile List
Table Microecological Modulator Operating Data of Apotex Inc. (Canada) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla (India) Profile List
Table Microecological Modulator Operating Data of Cipla (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis (Switzerland) Profile List
Table Microecological Modulator Operating Data of Novartis (Switzerland) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharma (India) Profile List
Table Microecological Modulator Operating Data of Sun Pharma (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Natco Pharma (India) Profile List
Table Microecological Modulator Operating Data of Natco Pharma (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Product Specifications of Iron Chelation Drug
Table Products Segment of Iron Chelation Drug
Table Deferoxamine Overview
Table Deferiprone Overview
Table Deferasirox Overview
Table Global Iron Chelation Drug Market by Type, 2011-2022 (USD Million)
Table Application Segment of Iron Chelation Drug
Table Transfusional Iron Overload Overview
Table NTDT Caused Iron Overload Overview
Table Global Iron Chelation Drug Market by Application, 2011-2022 (USD Million)
Table Global Iron Chelation Drug Market by Region, 2011-2022 (USD Million)
Table Cost of Iron Chelation Drug
Table Market Dynamics
Table Policy of Iron Chelation Drug
Table GDP of Major Countries
Table Deferoxamine CAGR by Revenue and Volume, 2012-2018
Table Deferiprone CAGR by Revenue and Volume, 2012-2018
Table Deferasirox CAGR by Revenue and Volume, 2012-2018
Table Deferoxamine CAGR by Revenue and Volume, 2012-2024
Table Deferiprone CAGR by Revenue and Volume, 2012-2024
Table Deferasirox CAGR by Revenue and Volume, 2012-2024
Table Transfusional Iron Overload CAGR by Revenue and Volume, 2012-2018
Table NTDT Caused Iron Overload CAGR by Revenue and Volume, 2012-2018
Table Global Iron Chelation Drug Market by Vendors, 2012-2018 (USD Million)
Table Global Iron Chelation Drug Market by Vendors, 2012-2018 (in Volume)
Table Global Iron Chelation Drug Market Share by Vendors, 2012-2018 (USD Million)
Table Global Iron Chelation Drug Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Apotex Inc. (Canada) Profile List
Table Microecological Modulator Operating Data of Apotex Inc. (Canada) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla (India) Profile List
Table Microecological Modulator Operating Data of Cipla (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis (Switzerland) Profile List
Table Microecological Modulator Operating Data of Novartis (Switzerland) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharma (India) Profile List
Table Microecological Modulator Operating Data of Sun Pharma (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Natco Pharma (India) Profile List
Table Microecological Modulator Operating Data of Natco Pharma (India) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
LIST OF FIGURES
Figure Iron Chelation Drug Picture
Figure Industry Chain Structure of Iron Chelation Drug
Figure SWOT of Iron Chelation Drug
Figure Deferoxamine Market Size and Growth, 2012-2018 (USD Million)
Figure Deferoxamine Market Size and Growth, 2012-2018 (in Volume)
Figure Deferiprone Market Size and Growth, 2012-2018 (USD Million)
Figure Deferiprone Market Size and Growth, 2012-2018 (in Volume)
Figure Deferasirox Market Size and Growth, 2012-2018 (USD Million)
Figure Deferasirox Market Size and Growth, 2012-2018 (in Volume)
Figure Deferoxamine Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Deferoxamine Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Deferiprone Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Deferiprone Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Deferasirox Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Deferasirox Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Transfusional Iron Overload Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure NTDT Caused Iron Overload Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Iron Chelation Drug Market Concentration by Region
Figure Marketing Channels Overview
Figure Iron Chelation Drug Picture
Figure Industry Chain Structure of Iron Chelation Drug
Figure SWOT of Iron Chelation Drug
Figure Deferoxamine Market Size and Growth, 2012-2018 (USD Million)
Figure Deferoxamine Market Size and Growth, 2012-2018 (in Volume)
Figure Deferiprone Market Size and Growth, 2012-2018 (USD Million)
Figure Deferiprone Market Size and Growth, 2012-2018 (in Volume)
Figure Deferasirox Market Size and Growth, 2012-2018 (USD Million)
Figure Deferasirox Market Size and Growth, 2012-2018 (in Volume)
Figure Deferoxamine Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Deferoxamine Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Deferiprone Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Deferiprone Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Deferasirox Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Deferasirox Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Transfusional Iron Overload Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure NTDT Caused Iron Overload Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Iron Chelation Drug Market Concentration by Region
Figure Marketing Channels Overview
